/
/
/

Transgene Biotek Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2013Mar 2012
₹6 L₹6 L₹6 L₹5 L₹5 L₹8 L₹8 L₹6 L₹5 L₹5 L₹5 L₹10 L₹0₹0₹0₹6 L₹9 L₹0₹20,000₹0₹1 L₹16 L₹0₹0₹40,000₹0₹0₹0₹0₹0₹0₹7 L₹62 L₹5 Cr
₹0₹15 L₹0₹0₹0₹4 L₹4 L₹4 L₹65 L₹5 L₹4 L₹4 L₹4 L₹4 L₹4 L₹4 L₹8 L₹4 L₹4 L₹4 L₹13 L₹5 L₹4 L₹4 L₹4 L₹4 L₹5 L₹4 L₹2 Cr₹4 L₹4 L₹4 L₹3 L₹10,000
₹6 L₹20 L₹6 L₹5 L₹5 L₹12 L₹12 L₹10 L₹70 L₹10 L₹9 L₹14 L₹4 L₹4 L₹4 L₹10 L₹17 L₹4 L₹5 L₹4 L₹14 L₹21 L₹4 L₹4 L₹4 L₹4 L₹5 L₹4 L₹2 Cr₹4 L₹4 L₹12 L₹65 L₹5 Cr
₹16 L₹39 L₹16 L₹18 L₹24 L₹64 L₹19 L₹16 L₹48 L₹34 L₹18 L₹24 L₹1 Cr₹1 Cr₹2 Cr₹1 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹1 Cr₹5 Cr
-₹6 L-₹13 L-₹5 L-₹7 L-₹14 L-₹50 L-₹5 L-₹3 L₹24 L-₹22 L-₹6 L-₹8 L-₹19 L-₹10 L-₹49 L-₹11 L₹2 L-₹12 L-₹8 L-₹8 L-₹6 L₹3 L-₹13 L-₹10 L-₹24 L-₹11 L-₹18 L-₹15 L₹2 Cr-₹16 L-₹8 L-₹2 L-₹9 L₹24 L
₹29 L₹28 L₹27 L₹26 L₹25 L₹19 L₹2 L₹2 L₹2 L₹3 L₹3 L₹3 L₹5 L₹5 L₹5 L₹5 L₹6 L₹6 L₹6 L₹6 L₹7 L₹7 L₹7 L₹7 L₹8 L₹8 L₹8 L₹16 L₹6 L₹6 L₹13 L₹0-₹9 L₹12 L
-₹39 L-₹46 L-₹37 L-₹39 L-₹43 L-₹71 L-₹9 L-₹7 L₹20 L-₹27 L-₹12 L-₹13 L-₹1 Cr-₹1 Cr-₹2 Cr-₹1 Cr-₹3 Cr-₹3 Cr-₹3 Cr-₹3 Cr-₹3 Cr-₹3 Cr-₹3 Cr-₹3 Cr-₹3 Cr-₹3 Cr-₹3 Cr-₹3 Cr-₹90 L-₹93 L-₹3 Cr-₹2 Cr-₹73 L-₹8 Cr
-₹39 L-₹46 L-₹37 L-₹39 L-₹43 L-₹71 L-₹9 L-₹7 L₹20 L-₹27 L-₹12 L-₹13 L-₹1 Cr-₹1 Cr-₹2 Cr-₹1 Cr-₹3 Cr-₹3 Cr-₹3 Cr-₹3 Cr-₹3 Cr-₹3 Cr-₹3 Cr-₹3 Cr-₹3 Cr-₹3 Cr-₹3 Cr-₹3 Cr-₹90 L-₹93 L-₹3 Cr-₹2 Cr-₹73 L-₹5 Cr

Share Price Live Stats

Open (₹)2.82
Volume (₹)27,347.00
High (₹)2.82
Upper Circuit3.32
Low (₹)2.65
Lower Circuit2.22
Prev Close2.77
52W High (₹)4.50
Price2.70
52W Low (₹)1.83

Share Market Cap & Key Ratios Overview

M.Cap (₹)20.99 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity1.45
Price to Book2.53
Book Value1.32
EPS (TTM)-0.21
Face Value10.00
ROE (%)-6.52

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SAGILITY-ANSE
SYNGENE-ANSE
INDGN-ANSE
IGIL-ANSE
NESCO-ANSE
JUSTDIAL-ANSE
LATENTVIEW-ANSE
CMSINFO-ANSE
MEDIASSIST-ANSE
AWFIS-ANSE
TRABI-XNSE
LTP
1W Low
1W High
Market cap (₹)
46.96+0.56 (1.21%)
45.85
47.47
21,885Cr
397.7-5.7 (-1.41%)
395.10
407.50
16,169Cr
601.65+23 (3.97%)
579.95
616
14,458Cr
327.5-11.85 (-3.49%)
321.35
346.50
14,065Cr
1050+1.7 (0.16%)
1028.80
1065.90
7,366Cr
692-12.65 (-1.80%)
688.90
734
5,918Cr
269.75-10.75 (-3.83%)
265.20
278.60
5,504Cr
243.75+1.2 (0.49%)
238.35
253.95
3,918Cr
345.5+12 (3.60%)
328
348.50
2,567Cr
261.65+8.1 (3.19%)
250.95
268.70
1,835Cr
2.7-0.2 (-6.90%)
2.60
2.95
21Cr

Key Highlights of Transgene Biotek Ltd’s P&L

In 2025-03-31, Transgene Biotek Ltd reported total revenue of ₹1.04Cr, compared with ₹41.76Lakh in 2024-03-31, reflecting Transgene Biotek Ltd turnover.

Depreciation was ₹9.32Lakh and finance costs were ₹24.49Lakh in 2025-03-31

Profit Before Tax (PBT) has been ₹-₹67.61Lakh in 2025-03-31 as compared to ₹-₹65.55Lakh in 2024-03-31.

Net Profit (PAT) was ₹-₹67.61Lakh in 2025-03-31 compared with ₹-₹65.55Lakh in 2024-03-31.

Earnings per share (EPS) were ₹-0.09 in 2025-03-31, compared with ₹-0.09 in 2024-03-31.